Correspondence 0001960682-23-000004 from Starpax Biopharma Inc. (CIK 0001960682)
Starpax Biopharma Inc. (CIK 0001960682)
Date: Sept. 6, 2023 · CIK: 0001960682 · Accession: 0001960682-23-000004
AI Filing Summary & Sentiment
File numbers found in text: 024-12149
Letter
Re: Starpax Biopharma Inc.
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
September 6, 2023
Amendment No. 1 to Offering Statement on Form 1-A/A
File No. 024-12149
Ladies and Gentlemen:
On behalf of Starpax Biopharma Inc. (the “Company”), I hereby request qualification of the above-referenced offering statement (filed August 15, 2023) at 12:00PM, Eastern Time, on Monday September 11, 2023, or as soon thereafter as is practicable.
Sincerely,
s/ Michael Gareau
Show Raw Text
CORRESP
1
filename1.htm
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
September 6, 2023
Re:
Starpax Biopharma Inc.
Amendment No. 1 to Offering Statement on Form 1-A/A
File No. 024-12149
Ladies and Gentlemen:
On behalf of Starpax Biopharma Inc. (the “Company”), I
hereby request qualification of the above-referenced offering statement (filed August 15, 2023) at 12:00PM, Eastern Time, on
Monday September 11, 2023, or as soon thereafter as is practicable.
Sincerely,
s/ Michael Gareau
Chairman of the Board of Directors, CEO
Starpax Biopharma Inc.